Imbalance in the oral bacterial flora as a risk factor for acute exacerbation in idiopathic pulmonary fibrosis

S. Ohshimo (Hiroshima, Japan), H. Nishi (Hiroshima, Japan), K. Hosokawa (Hiroshima, Japan), Y. Horimasu (Hiroshima, Japan), S. Miyamoto (Hiroshima, Japan), H. Iwamoto (Hiroshima, Japan), H. Hamada (Hiroshima, Japan), . Kawaguchi (Hiroshima, Japan), F. Bonella (Essen, Germany), J. Guzman (Bochum, Germany), U. Costabel (Essen, Germany), N. Hattori (Hiroshima, Japan), N. Shime (Hiroshima, Japan)

Source: International Congress 2019 – The evolving field of idiopathic interstitial pneumonia
Session: The evolving field of idiopathic interstitial pneumonia
Session type: Oral Presentation
Number: 1926
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Ohshimo (Hiroshima, Japan), H. Nishi (Hiroshima, Japan), K. Hosokawa (Hiroshima, Japan), Y. Horimasu (Hiroshima, Japan), S. Miyamoto (Hiroshima, Japan), H. Iwamoto (Hiroshima, Japan), H. Hamada (Hiroshima, Japan), . Kawaguchi (Hiroshima, Japan), F. Bonella (Essen, Germany), J. Guzman (Bochum, Germany), U. Costabel (Essen, Germany), N. Hattori (Hiroshima, Japan), N. Shime (Hiroshima, Japan). Imbalance in the oral bacterial flora as a risk factor for acute exacerbation in idiopathic pulmonary fibrosis. 1926

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis
Source: Eur Respir Rev, 28 (152) 190045; 10.1183/16000617.0045-2019
Year: 2019



Difference between pathogenic and inhibitory bacterial florae is associated with acute exacerbation of idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020


Relationship between bacterial flora and pulmonary function in patients with acute exacerbations of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 566s
Year: 2003

Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010


Bacterial infections in patients with acute exacerbation of chronic obstructive pulmonary diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002

Sputum microbiome richness is decreased in patients treated for acute exacerbations of eosinophilic chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020

Acute exacerbations of idiopathic pulmonary fibrosis and the role of corticosteroids
Source: Breathe, 16 (3) 200086; 10.1183/20734735.0086-2020
Year: 2020



Chronic bronchitis: a risk factor for bronchial infection
Source: Eur Respir Monogr 2013; 60: 18-26
Year: 2013


Differences of acute exacerbations in idiopathic pulmonary fibrosis compared to other fibrotic lung diseases
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019

Eosinopenia as a prognostic factor in patients with acute exacerbation of chronic obstructive pulmonary disease.
Source: International Congress 2017 – COPD and weaning
Year: 2017

The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010


Tumor-associated antigens in acute exacerbation of idiopathic pulmonary fibrosis: Associations with disease activity
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010

Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease
Source: Eur Respir J , 49 (3) 1601328; DOI: 10.1183/13993003.01328-2016
Year: 2017



Role of colonization on inflammation in COPD patients with bronchiectasis
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Asymmetry in acute exacerbation of idiopathic pulmonary fibrosis
Source: ERJ Open Res, 3 (2) 00036-2016; 10.1183/23120541.00036-2016
Year: 2017



Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
Source: Eur Respir J 2011; 37: 356
Year: 2011



Bacterial infection in acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012

The role of chlamydia pneumoniae infection in acute purulent exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 221s
Year: 2002

The role of bronchial bacterial infection/colonization in acute exacerbation of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 284s
Year: 2005

Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis
Source: Eur Respir J 2012; 40: 93-100
Year: 2012